MicroRNA in various aspects of cancer development

Sho Nambara, Koshi Mimori

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

MicroRNAs (miRNAs) are small (18-25 nucleotides) noncoding RNA molecules that bind to partially complementary mRNA sequences, resulting in target degradation or translation inhibition. A single miRNA can influence the expression of hundreds of target genes, and miRNAs have been implicated as key molecules in various diseases, including cancer. Many studies have shown that the miRNAs play an important role in cancer cells and tumor microenvironment and may be biomarkers for early detection and therapeutic targets for various cancers. Recently, relationships between miRNAs and immunocheckpoint molecules have been focused on as new tumor progression associated mechanisms. As for biomarkers, cell-free miRNAs detected in body fluids (circulating miRNAs) have attached the attention of researchers due to their potential as tumor-specific and non-invasive biomarkers. In terms of strategies to use miRNAs as therapeutic targets, developments of tissue specific delivery systems, including lipid nanoparticles or exosome vectors, are progressing. Here we will review the mechanisms and clinical uses of miRNAs in cancer.

Original languageEnglish
Pages (from-to)362-366
Number of pages5
JournalJapanese Journal of Cancer and Chemotherapy
Volume44
Issue number5
Publication statusPublished - May 1 2017

Fingerprint

MicroRNAs
Neoplasms
Tumor Microenvironment
Biomarkers
Exosomes
Cellular Microenvironment
Untranslated RNA
Body Fluids
Nanoparticles
Nucleotides
Research Personnel
Lipids
Messenger RNA
Therapeutics
Genes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

MicroRNA in various aspects of cancer development. / Nambara, Sho; Mimori, Koshi.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 44, No. 5, 01.05.2017, p. 362-366.

Research output: Contribution to journalArticle

@article{29aabb1137b944c3b8c65add56758e55,
title = "MicroRNA in various aspects of cancer development",
abstract = "MicroRNAs (miRNAs) are small (18-25 nucleotides) noncoding RNA molecules that bind to partially complementary mRNA sequences, resulting in target degradation or translation inhibition. A single miRNA can influence the expression of hundreds of target genes, and miRNAs have been implicated as key molecules in various diseases, including cancer. Many studies have shown that the miRNAs play an important role in cancer cells and tumor microenvironment and may be biomarkers for early detection and therapeutic targets for various cancers. Recently, relationships between miRNAs and immunocheckpoint molecules have been focused on as new tumor progression associated mechanisms. As for biomarkers, cell-free miRNAs detected in body fluids (circulating miRNAs) have attached the attention of researchers due to their potential as tumor-specific and non-invasive biomarkers. In terms of strategies to use miRNAs as therapeutic targets, developments of tissue specific delivery systems, including lipid nanoparticles or exosome vectors, are progressing. Here we will review the mechanisms and clinical uses of miRNAs in cancer.",
author = "Sho Nambara and Koshi Mimori",
year = "2017",
month = "5",
day = "1",
language = "English",
volume = "44",
pages = "362--366",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "5",

}

TY - JOUR

T1 - MicroRNA in various aspects of cancer development

AU - Nambara, Sho

AU - Mimori, Koshi

PY - 2017/5/1

Y1 - 2017/5/1

N2 - MicroRNAs (miRNAs) are small (18-25 nucleotides) noncoding RNA molecules that bind to partially complementary mRNA sequences, resulting in target degradation or translation inhibition. A single miRNA can influence the expression of hundreds of target genes, and miRNAs have been implicated as key molecules in various diseases, including cancer. Many studies have shown that the miRNAs play an important role in cancer cells and tumor microenvironment and may be biomarkers for early detection and therapeutic targets for various cancers. Recently, relationships between miRNAs and immunocheckpoint molecules have been focused on as new tumor progression associated mechanisms. As for biomarkers, cell-free miRNAs detected in body fluids (circulating miRNAs) have attached the attention of researchers due to their potential as tumor-specific and non-invasive biomarkers. In terms of strategies to use miRNAs as therapeutic targets, developments of tissue specific delivery systems, including lipid nanoparticles or exosome vectors, are progressing. Here we will review the mechanisms and clinical uses of miRNAs in cancer.

AB - MicroRNAs (miRNAs) are small (18-25 nucleotides) noncoding RNA molecules that bind to partially complementary mRNA sequences, resulting in target degradation or translation inhibition. A single miRNA can influence the expression of hundreds of target genes, and miRNAs have been implicated as key molecules in various diseases, including cancer. Many studies have shown that the miRNAs play an important role in cancer cells and tumor microenvironment and may be biomarkers for early detection and therapeutic targets for various cancers. Recently, relationships between miRNAs and immunocheckpoint molecules have been focused on as new tumor progression associated mechanisms. As for biomarkers, cell-free miRNAs detected in body fluids (circulating miRNAs) have attached the attention of researchers due to their potential as tumor-specific and non-invasive biomarkers. In terms of strategies to use miRNAs as therapeutic targets, developments of tissue specific delivery systems, including lipid nanoparticles or exosome vectors, are progressing. Here we will review the mechanisms and clinical uses of miRNAs in cancer.

UR - http://www.scopus.com/inward/record.url?scp=85026522346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026522346&partnerID=8YFLogxK

M3 - Article

C2 - 28536328

AN - SCOPUS:85026522346

VL - 44

SP - 362

EP - 366

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 5

ER -